# Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia

> **NCT04614974** · PHASE1,PHASE2 · TERMINATED · sponsor: **Reema Padia** · enrollment: 65 (actual)

## Conditions studied

- Laryngomalacia
- Gastro Esophageal Reflux

## Interventions

- **DRUG:** Famotidine
- **OTHER:** Speech Language Therapy

## Key facts

- **NCT ID:** NCT04614974
- **Lead sponsor:** Reema Padia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-18
- **Primary completion:** 2024-05-17
- **Final completion:** 2024-05-17
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Slow recruitment due to few eligible patients
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614974, "Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04614974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*